Medica S.p.A. Stock

Equities

MDC

IT0005460149

Biotechnology & Medical Research

Market Closed - Borsa Italiana 11:44:59 2024-05-21 EDT 5-day change 1st Jan Change
26.4 EUR 0.00% Intraday chart for Medica S.p.A. 0.00% +70.32%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 93.11M 101M 138M Sales 2025 * 102M 110M 151M Capitalization 111M 121M 165M
Net income 2024 * 6M 6.51M 8.9M Net income 2025 * 9M 9.77M 13.35M EV / Sales 2024 * 1.26 x
Net Debt 2024 * 5.92M 6.42M 8.77M Net cash position 2025 * 4.79M 5.2M 7.1M EV / Sales 2025 * 1.05 x
P/E ratio 2024 *
16.3 x
P/E ratio 2025 *
11.9 x
Employees 696
Yield 2024 *
-
Yield 2025 *
-
Free-Float 20.07%
More Fundamentals * Assessed data
Dynamic Chart
1 month+0.76%
3 months+69.23%
6 months+61.96%
Current year+70.32%
More quotes
1 week
26.40
Extreme 26.4
26.60
1 month
26.20
Extreme 26.2
26.80
Current year
14.50
Extreme 14.5
26.80
1 year
14.40
Extreme 14.4
26.80
3 years
14.40
Extreme 14.4
45.80
5 years
14.40
Extreme 14.4
45.80
10 years
14.40
Extreme 14.4
45.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 10-12-31
Chairman 75 89-12-31
Chief Administrative Officer 58 94-12-31
Members of the board TitleAgeSince
Director/Board Member 54 21-10-13
Chairman 75 89-12-31
Chief Executive Officer 41 10-12-31
More insiders
Date Price Change Volume
24-05-21 26.4 0.00% 500
24-05-20 26.4 0.00% 150
24-05-17 26.4 -0.75% 1,850
24-05-16 26.6 0.00% 0
24-05-15 26.6 +0.76% 2,200

Real-time Borsa Italiana, May 21, 2024 at 05:01 am

More quotes
Medica SpA is an Italy-based company primarily engaged in designing, manufacturing and supplying blood purification systems. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. It also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. It is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The Company provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. It operates globally.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
26.4 EUR
Average target price
31.4 EUR
Spread / Average Target
+18.94%
Consensus

Annual profits - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW